Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cancers|October 14, 2022
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 IsoformEsmaeil Dorraji, Elin Borgen, Dario Segura-Peña, et al.
Molecular Therapy Oncolytics|July 21, 2022
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancerYixin Jin, Kristina Berg Lorvik, Yang Jin, et al.
Oncoimmunology|December 22, 2016
Immune response and long-term clinical outcome in advanced melanoma patients vaccinated with tumor-mRNA-transfected dendritic cellsJon Amund Kyte, Steinar Aamdal, Svein Dueland, et al.
Oncoimmunology|January 27, 2017
T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapyJon Amund Kyte, Gustav Gaudernack, Anne Faane, et al.
Molecular Oncology|November 15, 2024
Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancerAndreas Ullern, Kristian Holm, Andreas Hagen Røssevold, et al.
Journal for Immunotherapy of Cancer|July 20, 2026
Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trialAndreas Ullern, Kjetil Kjelstad Garborg, Sudhir Kumar Chauhan, et al.
Frontiers in Immunology|December 16, 2020
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung CancerPaal F Brunsvig, Tormod Kyrre Guren, Marta Nyakas, et al.
International Journal of Cancer|June 21, 2013
Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanomaAna B del Campo, Jon Amund Kyte, Javier Carretero, et al.
NPJ Breast Cancer|April 23, 2024
Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammationSudhir Kumar Chauhan, Claire Dunn, Nikolai Kragøe Andresen, et al.
Clinical & Translational Immunology|December 20, 2016
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary diseaseHanne Astrid Eide, Ann Rita Halvorsen, Vandana Sandhu, et al.
Pageof 5